Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant human erythropoietin in anemic cancer patients undergoing chemotherapy
jRCT2080220012Phase 3
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Sep 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of erythropoietin in anaemia and cancer, sponsored by Chugai Pharmaceutical Co., Ltd.
02
Drugs
erythropoietin
03
Conditions
anaemiacancer
Beyond the preview
Go deeper on jRCT2080220012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220012.